Company Filing History:
Years Active: 2019
Title: Dite Venskus: Innovator in Oncolytic Virus Research
Introduction
Dite Venskus is a notable inventor based in Jelgava, Latvia. He has made significant contributions to the field of biotechnology, particularly in the development of oncolytic viruses for cancer treatment. With a total of 2 patents, his work focuses on innovative methods for manufacturing genetically stable oncolytic RNA viruses.
Latest Patents
Venskus's latest patents include a method for manufacturing a modified enterovirus of ECHO 7 type. This method involves the adaptation of the native ECHO 7 virus, which is isolated from human feces and identified by genome sequence. The process begins with the adaptation of the virus in cancer cells that have been attenuated by the anti-cancer agent dacarbazine. Following this, the modified virus is passaged in human embryonal fibroblast culture, propagated in human melanoma cells, and further passaged in fibroblast culture treated with ribavirin. The isolation and purification are conducted using known methods. The modified virus developed through this process is suitable for treating various tumors.
Career Highlights
Throughout his career, Dite Venskus has worked with several companies, including Ditesan Ltd. and Sia Latima. His experience in these organizations has contributed to his expertise in the field of biotechnology and oncolytic virus research.
Collaborations
Some of his notable coworkers include Ivars Kalvins and Dace Pjanova, who have collaborated with him on various projects related to his research.
Conclusion
Dite Venskus is a pioneering inventor whose work in oncolytic virus research holds promise for advancing cancer treatment. His innovative methods and collaborations highlight his commitment to improving therapeutic options for patients.